Brief: Chordate Medical Gets CE marking For K.O.S Method Against Chronic Migraine

Chordate Medical Holding AB (publ)

11/05/2021 08:53

May 11 (Reuters) - Chordate Medical  CMHM.NGM  :
    * SAID ON MONDAY RECEIVED CE MARKING FOR THE K.O.S METHOD
AGAINST
CHRONIC MIGRAINE - ONE YEAR AHEAD OF SCHEDULE
    * THE CE MARKING MEANS THAT K.O.S MEETS THE REQUIREMENTS FOR
CLINICAL EFFICACY AND SAFETY FOR CHRONIC MIGRAINE IN THE
EUROPEAN DIRECTIVE ON MEDICAL DEVICES
    * THE CONSENT ALLOWS CHORDATE TO COMMERCIALIZE MIGRAINE
TREATMENT
FREELY WITHIN THE EU 

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nBQN40RSW7
    
 Further company coverage:  CMHM.NGM  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))